Samuel S. Pereira

Av. Prof. Lineu Prestes, 1374
Sao Paulo, SP, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Standardization of C6/36 cells for DENV-2 virological assays: isolation, TCID₅₀ and serum neutralization.

Standardization of C6/36 cells for DENV-2 virological assays: isolation, TCID₅₀ and serum neutralization.

Journal: BMC research notes

Published: October 01, 2025

Seroprevalence and Placental Transfer of Zika and Dengue Virus Antibodies in Postpartum Women in Southeast Brazil.

Seroprevalence and Placental Transfer of Zika and Dengue Virus Antibodies in Postpartum Women in Southeast Brazil.

Journal: Journal of medical virology

Published: March 11, 2025

Serotype-Specific Dengue Virus IgG Assay Using EDIII-Based Recombinant Proteins and Its Application in an Endemic Population in Northeast Brazil.

Serotype-Specific Dengue Virus IgG Assay Using EDIII-Based Recombinant Proteins and Its Application in an Endemic Population in Northeast Brazil.

Journal: Journal of medical virology

Published: July 27, 2024

Multi-epitope Antigen for Specific Serological Detection of Dengue Viruses.

Multi-epitope Antigen for Specific Serological Detection of Dengue Viruses.

Journal: Viruses

Published: August 14, 2023

The Anti-Dengue Virus Peptide DV2 Inhibits Zika Virus Both In Vitro and In Vivo.

The Anti-Dengue Virus Peptide DV2 Inhibits Zika Virus Both In Vitro and In Vivo.

Journal: Viruses

Published: March 03, 2023

The third vaccine dose significantly reduces susceptibility to the B.1.1.529 (Omicron) SARS-CoV-2 variant.

The third vaccine dose significantly reduces susceptibility to the B.1.1.529 (Omicron) SARS-CoV-2 variant.

Journal: Journal of medical virology

Published: November 16, 2022

Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells.

Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells.

Journal: Frontiers in immunology

Published: October 15, 2022

NS1-based ELISA test efficiently detects dengue infections without cross-reactivity with Zika virus.

NS1-based ELISA test efficiently detects dengue infections without cross-reactivity with Zika virus.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: May 24, 2021

Corrigendum: Protective Immunity to Dengue Virus Induced by DNA Vaccines Encoding Nonstructural Proteins in a Lethal Challenge Immunocompetent Mouse Model.

Corrigendum: Protective Immunity to Dengue Virus Induced by DNA Vaccines Encoding Nonstructural Proteins in a Lethal Challenge Immunocompetent Mouse Model.

Journal: Frontiers in medical technology

Published: November 04, 2020

Enhanced Immune Responses and Protective Immunity to Zika Virus Induced by a DNA Vaccine Encoding a Chimeric NS1 Fused With Type 1 Herpes Virus gD Protein.

Enhanced Immune Responses and Protective Immunity to Zika Virus Induced by a DNA Vaccine Encoding a Chimeric NS1 Fused With Type 1 Herpes Virus gD Protein.

Journal: Frontiers in medical technology

Published: September 08, 2020

Nanovaccine based on self-assembling nonstructural protein 1 boosts antibody responses to Zika virus.

Nanovaccine based on self-assembling nonstructural protein 1 boosts antibody responses to Zika virus.

Journal: Nanomedicine : nanotechnology, biology, and medicine

Published: August 18, 2020

Novel antigenic proteins of Mycoplasma agalactiae as potential vaccine and serodiagnostic candidates.

Novel antigenic proteins of Mycoplasma agalactiae as potential vaccine and serodiagnostic candidates.

Journal: Veterinary microbiology

Published: May 07, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026